Roche's Emicizumab for Haemophilia A Meets All Endpoints
Roche today announces that its drug candidate for Haemophilia A has reached its primary endpoint in the phase III HAVEN 1 study, as well as all secondary endpoints.
Roche (OTCQX:RHHBY) today announces that its drug candidate for Haemophilia A has reached its primary endpoint in the phase III HAVEN 1 study, as well as all secondary endpoints.
According to the press release:
“The study showed a statistically significant reduction in the number of bleeds over time in people treated with emicizumab prophylaxis compared to those receiving no prophylactic treatment.”
Sandra Horning, Roche’s Chief Medical Officer, said the following:
“We are pleased to see that, in our first pivotal trial, emicizumab prophylaxis significantly reduced the number of bleeds over time in people in this difficult-to-treat setting. We look forward to working with health authorities to bring this treatment to the haemophilia community as soon as possible.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1807.22 | -1.19 | |
Silver | 19.93 | +0.07 | |
Copper | 3.57 | -0.14 | |
Palladium | 1941.50 | -3.50 | |
Platinum | 887.00 | +1.00 | |
Oil | 110.57 | +4.81 | |
Heating Oil | 3.95 | +0.12 | |
Natural Gas | 5.84 | +0.23 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.